China BCT Posts 2010 SAIC Reports to its Website

LIUZHOU CITY, China, July 19, 2011 /PRNewswire-Asia/ -- China BCT Pharmacy Group, Inc., (OTC BB: CNBI), (“China BCT” or the “Company”), a leading pharmaceutical distributor, retail pharmacy, and manufacturer of pharmaceutical products in Guangxi Province, China, today announced that the Company has posted its 2010 State Administration for Industry and Commerce (“SAIC”) reports, along with a reconciliation to certain corresponding figures disclosed in the Company’s 2010 U.S. Securities and Exchange Commission (“SEC”) filings, to the Investor Relations section of its web site at: http://ir.stockpr.com/chinabct/SAIC_Reports.

“In addition to corporate presentations, press releases, SEC filings and other shareholder resources, we have posted the 2010 SAIC reports for each of China BCT’s three subsidiaries to our website,” commented Mr. Hui Tian Tang, Chairman and Chief Executive Officer of China BCT Pharmacy Group, Inc. “By providing investors with financial information above and beyond required disclosure, we aim to promote transparency and differentiate our Company from our peers,” Mr. Tang concluded.

About China BCT

China BCT is engaged in pharmaceutical distribution, pharmacy retailing, and the manufacture of pharmaceuticals products through its subsidiaries Guangxi Liuzhou Baicaotang Medicine Limited, Guangxi Liuzhou Baicaotang Medicine Retail Limited, and Hefeng Pharmaceutical Co. Limited in Guangxi province, China. It operates a large regional retail network in Guangxi province, consisting of 187 directly owned retail stores in Guangxi province and currently over 8,000 products are distributed through the Company’s wholesale distribution network. For more information, please visit www.china-bct.com.

SOURCE China BCT Pharmacy Group, Inc.